Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olumiant (baricitinib)
Pharma
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
In a win against autoimmune rival Incyte, a U.S. appeals court has tossed an injunction blocking Sun Pharma from launching its alopecia med Leqselvi.
Fraiser Kansteiner
Apr 10, 2025 10:00am
Incyte wins injunction to block Sun's Leqselvi launch
Nov 4, 2024 10:01am
Lilly strikes Olumiant licensing deal with Egypt's Eva Pharma
Sep 4, 2024 10:49am
Sun Pharma snags FDA OK for alopecia areata drug Leqselvi
Jul 26, 2024 10:57am
Pfizer's Litfulo boasts an alopecia edge over Lilly's Olumiant
Jun 26, 2023 9:30am
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Nov 16, 2022 10:43am
